Singular Genomics Systems investor relations material

Singular Genomics Systems, Inc. is a life science technology company focused on developing next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company's technologies are used to advance human health by enabling the collection of the world's most comprehensive dataset of genomic information from any living thing—including plants, animals or single cells. This comprehensive dataset of molecular information is then analyzed by its software suite, which provides evidence for new discoveries, disease treatments, cures and diagnostics. Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California.